Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.66B |
| 2 |
ORIG
Ocean Rig UDW Inc. Class A Common Shares
ORIG
|
+$1.55B |
| 3 |
RTX Corp
RTX
|
+$664M |
| 4 |
NXP Semiconductors
NXPI
|
+$606M |
| 5 |
Walt Disney
DIS
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$1.46B |
| 2 |
KKR & Co
KKR
|
+$602M |
| 3 |
Meta Platforms (Facebook)
META
|
+$594M |
| 4 |
Mastercard
MA
|
+$560M |
| 5 |
Visa
V
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.15% |
| 2 | Technology | 10.69% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CRTN
6201
DELISTED
Cartesian, Inc.
CRTN
| $3K | ﹤0.01% |
4,000
-1,421
| -26% | -$923 |
2014 Q3
12 quarters
|
|
|
EMMS
6202
DELISTED
Emmis Communications Corp
EMMS
| $3K | ﹤0.01% |
942
-7,797
| -89% | -$20.7K |
2013 Q2
17 quarters
|
|
|
CBMX
6203
DELISTED
CombiMatrix Corporation
CBMX
| $3K | ﹤0.01% |
521
+455
| +689% | +$3.09K |
2013 Q4
15 quarters
|
|
|
CHII
6204
DELISTED
Global X MSCI China Industrials ETF
CHII
| $3K | ﹤0.01% |
170
+120
| +240% | +$1.8K |
2015 Q2
9 quarters
|
|
|
WMLP
6205
DELISTED
Westmoreland Resrc Partners, L.P
WMLP
| $3K | ﹤0.01% |
1,083
+661
| +157% | +$1.86K |
2015 Q1
10 quarters
|
|
|
JJN
6206
DELISTED
iPath Bloomberg Nickel Subindex Total Return ETN due October 22, 2037
JJN
| $3K | ﹤0.01% |
263
+100
| +61% | +$1.26K |
2015 Q4
7 quarters
|
|
|
ETRM
6207
DELISTED
EnteroMedics Inc.
ETRM
| $3K | ﹤0.01% |
1,564
+453
| +41% | +$1.33K |
2013 Q2
17 quarters
|
|
6208
DELISTED
CASI Pharmaceuticals
CASI
| $2K | ﹤0.01% |
116
+3
| +3% | +$35 |
2014 Q3
12 quarters
|
|
6209
Presurance Holdings
PRHI
$31M
| $2K | ﹤0.01% |
59
-572
| -91% | -$26.8K |
2015 Q4
7 quarters
|
|
6210
CorMedix
CRMD
$575M
| $2K | ﹤0.01% |
842
-695
| -45% | -$1.44K |
2014 Q1
14 quarters
|
|
6211
Electromed
ELMD
$229M
| $2K | ﹤0.01% |
296
-362
| -55% | -$2.37K |
2016 Q1
6 quarters
|
|
6212
DELISTED
FlexShopper
FPAY
| $2K | ﹤0.01% |
+285
| New | +$1.28K |
2017 Q3
0 quarters
|
|
6213
Star Equity Holdings
STRR
$38.1M
| $2K | ﹤0.01% |
105
-32
| -23% | -$452 |
2013 Q2
17 quarters
|
|
6214
Alpha Architect International Quantitative Value ETF
IVAL
$221M
| $2K | ﹤0.01% |
+65
| New | +$2.02K |
2017 Q3
0 quarters
|
|
6215
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$128M
| – | – |
-2
| Closed | -$24.1K | – |
|
6216
Limbach Holdings
LMB
$611M
| $2K | ﹤0.01% |
135
| – | – |
2016 Q4
3 quarters
|
|
|
BINI
6217
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
2016 Q2
5 quarters
|
|
6218
Paramount Gold Nevada
PZG
$100M
| $2K | ﹤0.01% |
1,363
-424
| -24% | -$655 |
2013 Q2
17 quarters
|
|
6219
iShares MSCI Qatar ETF
QAT
$55.2M
| $2K | ﹤0.01% |
153
-10,041
| -98% | -$168K |
2016 Q1
6 quarters
|
|
6220
Tenax Therapeutics
TENX
$70M
| – | – |
0
| – | – |
2015 Q2
9 quarters
|
|
6221
Zymeworks
ZYME
$1.85B
| $2K | ﹤0.01% |
300
| – | – |
2017 Q2
1 quarter
|
|
6222
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $2K | ﹤0.01% |
70
-54
| -44% | -$605 |
2017 Q2
1 quarter
|
|
6223
DELISTED
Reeds, Inc. Common Stock
REED
| $2K | ﹤0.01% |
18
| – | – |
2013 Q3
16 quarters
|
|
|
OBCI
6224
DELISTED
Ocean Bio-Chem Inc
OBCI
| $2K | ﹤0.01% |
370
-436
| -54% | -$1.87K |
2016 Q4
3 quarters
|
|
|
MFNC
6225
DELISTED
Mackinac Financial Corporation
MFNC
| $2K | ﹤0.01% |
130
-13
| -9% | -$186 |
2015 Q4
7 quarters
|
|
Similar funds
Morgan Stanley's Q3 2017 Portfolio in Review
As of Q3 2017, Morgan Stanley held 6,889 positions worth $334B, up 0.86% from $331B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q3 2017 filing shows 195 new, 3,466 increased, 2,508 reduced and 247 closed positions. Its largest new stake was JBG SMITH: 4,306,383 shares worth $147M. The largest sale was Reynolds American Inc, an estimated $1.46B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2017 buy was JBG SMITH: 4,306,383 shares worth $147M.
- Morgan Stanley added most to iShares MSCI Emerging Markets ETF in Q3 2017, an estimated $1.66B increase.
- Morgan Stanley's biggest Q3 2017 reduction was KKR & Co, cutting an estimated $602M.
- Morgan Stanley fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.46B.
- Morgan Stanley's ten largest holdings make up 12% of its $334B portfolio in Q3 2017.
- Morgan Stanley opened 195 new positions and closed 247 in Q3 2017.
- Morgan Stanley's portfolio value rose 0.86% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.